Clinical Trial Update: Vision Preservation and Restoration Following a 6 Month Trial of GlaucoCetin [NA]

View source ↗

Summary

A clinical trial of GlaucoCetin for primary open-angle glaucoma has been terminated after a six-month duration; no results are reported in the update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• GlaucoCetin

Snippet

Sponsor: Wills Eye | Conditions: Primary Open Angle Glaucoma | NA | Status: TERMINATED